Primary Sjögren's syndrome (pSS) is a chronic systemic autoimmune rheumatic disease
characterized by lymphoplasmacytic infiltration of the salivary and lacrimal glands, whereby …

Fatigue is common to all the rheumatic conditions, in varying degrees, and is a frequent,
often severe problem that has major consequences on patients' lives (1–4). In response to …

Objective To investigate whether rituximab, an anti–B cell therapy, improves symptoms of
fatigue and oral dryness in patients with primary Sjögren's syndrome (SS). Methods We …

Objectives To develop a score for assessment of patients' symptoms in primary Sjögren's
syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI). Methods Dryness, pain …

Primary Sjögren's syndrome (pSS) is a relatively common autoimmune systemic rheumatic
disease. In addition to sicca syndrome and swollen salivary glands, systemic features …

Chronic fatigue is one of the most prevalent and debilitating symptoms in primary SS (pSS).
Approximately 70% of pSS patients suffer from disabling fatigue, which is associated with …

Uveitis, a group of conditions characterized by intraocular inflammation, is a major cause of
sight loss in the working population. Most uveitis seen in Western countries is noninfectious …

Primary Sjögren's syndrome (pSS) is a heterogeneous disease characterised by a wide
spectrum of manifestations that vary according to the different stages of the disease and …

Sjögren's syndrome (SS) is a complex autoimmune rheumatic disease that specifically
targets salivary and lachrymal glands. As such, patients typically had ocular and oral …

In view of the new possibilities for the treatment of primary Sjögren's syndrome (pSS) given
by the availability of new biotechnological agents targeting the various molecular and …